News
CLB
--
0.00%
--
A Look At The Fair Value Of Core Laboratories N.V. (NYSE:CLB)
Today we will run through one way of estimating the intrinsic value of Core Laboratories N.V. ( NYSE:CLB ) by...
Simply Wall St. · 05/06 12:44
Core Labs (CLB) Stock Down 3% Since Q1 Earnings & Sales Beat
Core Laboratories' (CLB) stock down 3% since the company's first-quarter earnings and revenues beat estimates.
Zacks · 05/06 11:45
--Morgan Stanley Adjusts Core Laboratories' Price Target to $32 from $35, Keeps Equalweight Rating
MT Newswires · 05/02 12:35
Core Laboratories (CLB) Tops Q1 Earnings and Revenue Estimates
Core Laboratories (CLB) delivered earnings and revenue surprises of 33.33% and 3.29%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 04/27 22:35
BRIEF-Core Lab Posts Q1 EPS Of $0.04
reuters.com · 04/27 22:07
Core Laboratories declares $0.01 dividend
Core Laboratories (NYSE:CLB) declares $0.01/share quarterly dividend, in line with previous. Forward yield 0.15% Payable May 31; for shareholders of record May 9; ex-div May 6. See CLB Dividend Scorecard,
Seekingalpha · 04/27 21:23
Core Laboratories Q1 EPS $0.08 Beats $0.06 Estimate, Sales $115.30M Beat $106.84M Estimate
Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.06 by 33.33 percent. This is a 46.67 percent decrease over earnings of $0.15 per share from the
Benzinga · 04/27 21:22
Core Laboratories Non-GAAP EPS of $0.08 beats by $0.02, revenue of $115.3M beats by $3.52M
Core Laboratories press release (NYSE:CLB): Q1 Non-GAAP EPS of $0.08 beats by $0.02. Revenue of $115.3M (+6.4% Y/Y) beats by $3.52M. The company projects Q2 revenue to range from $119M
Seekingalpha · 04/27 21:21
CORE LAB REPORTS FIRST QUARTER 2022 RESULTS FROM CONTINUING OPERATIONS
Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported first quarter 2022 revenue of $115,300,000. Core's operating loss was $400,000, with a loss per diluted share of $0.04, all in accordan...
PR Newswire · 04/27 21:15
Core Laboratories Posts Lower Q1 Profit Amid Higher Revenue, Sets Q2 Outlook
MT Newswires · 04/27 17:55
-- Earnings Flash (CLB) CORE LABORATORIES N.V. Reports Q1 Revenue $115.3M, vs. Street Est of $111.8M
MT Newswires · 04/27 17:32
-- Earnings Flash (CLB) CORE LABORATORIES N.V. Posts Q1 EPS $0.08, vs. Street Est of $0.06
MT Newswires · 04/27 17:28
Core Laboratories Q1 2022 Earnings Preview
Core Laboratories (NYSE:CLB) is scheduled to announce Q1 earnings results on Wednesday, April 27th, after market close. The consensus EPS Estimate is $0.06 (-60.0% Y/Y) and the consensus Revenue Estimate
Seekingalpha · 04/26 22:35
A Preview Of Core Laboratories's Earnings
Core Laboratories (NYSE:CLB) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement. Analysts estimate that Core Laboratories will report an earnings per share (EPS) of $0.06...
Benzinga · 04/26 15:26
Is a Surprise Coming for Core Laboratories (CLB) This Earnings Season?
Core Laboratories (CLB) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zacks · 04/26 12:40
CP and Hapag-Lloyd announce additional seasonal call into Port Saint John
Canadian Pacific (NYSE: CP) (TSX: CP) and Hapag-Lloyd AG (XETR: HLAG) (FWB: HLG) today announced an additional call into Port Saint John, N.B., via a seasonal extra loader in another step forward for the growing Atlantic Canada port.
PR Newswire · 04/25 13:00
Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline
Core Laboratories (CLB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 04/20 19:02
Core Labs cut to Sell equivalent at Piper Sandler after nearly 50% YTD run-up
Core Laboratories (NYSE:CLB) slides nearly 2% after Piper Sandler downgraded shares to Underweight from Neutral even as it raises its stock price target to $21.30 from $19.50, saying the stock's
Seekingalpha · 04/18 18:57
Benzinga's Top Ratings Upgrades, Downgrades For April 18, 2022
Upgrades
Benzinga · 04/18 14:04
Piper Sandler Downgrades Core Laboratories to Underweight From Neutral
MT Newswires · 04/18 06:26
Webull provides a variety of real-time CLB stock news. You can receive the latest news about Core Laboratories N V through multiple platforms. This information may help you make smarter investment decisions.
About CLB
Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples. It provides analytical and field services to characterize properties of crude oil and petroleum products to the oil and gas industry. The Production Enhancement segment includes products and services relating to reservoir well completions, perforations, stimulations and production. It provides integrated diagnostic services to evaluate the effectiveness of well completions. The Reservoir Management segment combines and integrates information from reservoir description and production enhancement services to increase production and recovery of oil and gas from its clients' reservoirs.